Product Information
LEVORPHANOL 2 MG TABLET is a generic product labeled by Virtus Pharmaceuticals, LLC, priced at $10.6456 per EA under NDC 69543041710. Its NADAC has been published 95 times since Apr 17, 2024.
FDA first approved this application on Dec 13, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Virtus Pharmaceuticals, LLCNDC
69543041710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
LEVORPHANOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211484FDA Approved
12/13/2018
TE Code
AB
On Market Since
9/1/2020
Pharmacological Classes
Price Statistics
The NADAC for LEVORPHANOL 2 MG TABLET has been published 95 times since Apr 17, 2024, and over the history we have for it it has declined 33.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.6456 per EA |
|---|---|
| All-time high | $20.2966 (May 14, 2025) |
| All-time low | $10.6456 (Feb 18, 2026) |
| 52-week high | $16.1179 |
| 52-week low | $10.6456 |
| Median price | $16.1179 |
| Average price | $15.0742 |
| Largest weekly change | -16.6% (Feb 18, 2026) |
| Weeks tracked | 95 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
-34.0%
3Y
N/A
5Y
N/A
All
-33.8%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Virtus Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levorphanol Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVORPHANOL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVORPHANOL 2 MG TABLET, manufactured by Virtus Pharmaceuticals, LLC, is $10.6456 per EA (NDC 69543041710), effective Aug 19, 2026.
How has the price of LEVORPHANOL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVORPHANOL 2 MG TABLET has declined 33.8%. It has been tracked across 95 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LEVORPHANOL 2 MG TABLET?
Since Apr 17, 2024, the NADAC for LEVORPHANOL 2 MG TABLET has ranged from a low of $10.6456 (Feb 18, 2026) to a high of $20.2966 (May 14, 2025), with a median of $16.1179 per EA.
Are there cheaper alternatives to LEVORPHANOL 2 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVORPHANOL 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVORPHANOL 2 MG TABLET?
LEVORPHANOL 2 MG TABLET (NDC 69543041710) is labeled by Virtus Pharmaceuticals, LLC, and CMS classifies it as a generic product.